{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:58:30Z","timestamp":1781542710938,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["UG1CA189823"],"award-info":[{"award-number":["UG1CA189823"]}]},{"name":"North Central Cancer Treatment Group Community Clinical Oncology Program","award":["CA37404"],"award-info":[{"award-number":["CA37404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00520-016-3080-y","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T12:55:08Z","timestamp":1452862508000},"page":"2661-2667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)"],"prefix":"10.1007","volume":"24","author":[{"given":"Lisa","family":"Kottschade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Mazurczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"issue":"10","key":"3080_CR1","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, De Pouvourville G, Rubenstein EB, Daugaard G (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100(10):2261\u20132268. doi: 10.1002\/cncr.20230","journal-title":"Cancer"},{"issue":"10","key":"3080_CR2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.1985.3.10.1379","volume":"3","author":"MG Kris","year":"1985","unstructured":"Kris MG, Gralla RJ, Clark RA, Tyson LB, O\u2019Connell JP, Wertheim MS, Kelsen DP (1985) Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol Off J Am Soc Clin Oncol 3(10):1379\u20131384","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"3080_CR3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1200\/JCO.2001.19.6.1759","volume":"19","author":"D Campos","year":"2001","unstructured":"Campos D, Pereira JR, Reinhardt RR, Carracedo C, Poli S, Vogel C, Martinez-Cedillo J, Erazo A, Wittreich J, Eriksson LO, Carides AD, Gertz BJ (2001) Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone. J Clin Oncol Off J Am Soc Clin Oncol 19(6):1759\u20131767","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"3080_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1200\/JCO.1999.17.1.338","volume":"17","author":"PJ Hesketh","year":"1999","unstructured":"Hesketh PJ, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL (1999) Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11, 974 in the control of cisplatin-induced emesis. J Clin Oncol Off J Am Soc Clin Oncol 17(1):338\u2013343","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"3080_CR5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJM199901213400304","volume":"340","author":"RM Navari","year":"1999","unstructured":"Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh A, Kindler H, Grote TH, Pendergrass K, Grunberg SM, Carides AD, Gertz BJ (1999) Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754, 030 Antiemetic Trials Group. N Engl J Med 340(3):190\u2013195. doi: 10.1056\/nejm199901213400304","journal-title":"N Engl J Med"},{"issue":"22","key":"3080_CR6","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/cncr.28892","volume":"120","author":"DL Barton","year":"2014","unstructured":"Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL (2014) Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer 120(22):3575\u20133583. doi: 10.1002\/cncr.28892","journal-title":"Cancer"},{"issue":"27","key":"3080_CR7","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","volume":"24","author":"B Bloechl-Daum","year":"2006","unstructured":"Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients\u2032 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol Off J Am Soc Clin Oncol 24(27):4472\u20134478. doi: 10.1200\/jco.2006.05.6382","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"3080_CR8","first-page":"497","volume":"15","author":"L Cohen","year":"2007","unstructured":"Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 15(5):497\u2013503. doi: 10.1007\/s00520-006-0173-z","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"17","key":"3080_CR9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/jnci\/djs335","volume":"104","author":"LV dos Santos","year":"2012","unstructured":"dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP (2012) Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. J Natl Cancer Inst 104(17):1280\u20131292. doi: 10.1093\/jnci\/djs335","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3080_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.6004\/jnccn.2004.0039","volume":"2","author":"JA Roscoe","year":"2004","unstructured":"Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Shelke AR (2004) Biobehavioral factors in chemotherapy-induced nausea and vomiting. J Natl Compr Cancer Netw JNCCN 2(5):501\u2013508","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"6","key":"3080_CR11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1586\/14737167.2014.957683","volume":"14","author":"L Schwartzberg","year":"2014","unstructured":"Schwartzberg L (2014) Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting. Expert Rev Pharmacoecon Outcomes Res 14(6):825\u2013834. doi: 10.1586\/14737167.2014.957683","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"3080_CR12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2014-0229","volume":"20","author":"M Aapro","year":"2015","unstructured":"Aapro M, Carides A, Rapoport BL, Schmoll HJ, Zhang L, Warr D (2015) Aprepitant and fosaprepitant: a 10-year review of efficacy and safety. Oncologist 20(4):450\u2013458. doi: 10.1634\/theoncologist.2014-0229","journal-title":"Oncologist"},{"issue":"9","key":"3080_CR13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejca.2005.01.024","volume":"41","author":"DG Warr","year":"2005","unstructured":"Warr DG, Grunberg SM, Gralla RJ, Hesketh PJ, Roila F, Wit R, Carides AD, Taylor A, Evans JK, Horgan KJ (2005) The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: pooled data from 2 randomised, double-blind, placebo controlled trials. European J Cancer (Oxford, England: 1990) 41(9):1278\u20131285. doi: 10.1016\/j.ejca.2005.01.024","journal-title":"European J Cancer (Oxford, England: 1990)"},{"issue":"11","key":"3080_CR14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1200\/JCO.2010.31.7859","volume":"29","author":"S Grunberg","year":"2011","unstructured":"Grunberg S, Chua D, Maru A, Dinis J, DeVandry S, Boice JA, Hardwick JS, Beckford E, Taylor A, Carides A, Roila F, Herrstedt J (2011) Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol\u2013EASE. J Clin Oncol Off J Am Soc Clin Oncol 29(11):1495\u20131501. doi: 10.1200\/jco.2010.31.7859","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"3080_CR15","first-page":"843","volume":"19","author":"A Haiderali","year":"2011","unstructured":"Haiderali A, Menditto L, Good M, Teitelbaum A, Wegner J (2011) Impact on daily functioning and indirect\/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 19(6):843\u2013851. doi: 10.1007\/s00520-010-0915-9","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"1","key":"3080_CR16","first-page":"107","volume":"20","author":"DL Hilarius","year":"2012","unstructured":"Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK (2012) Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 20(1):107\u2013117. doi: 10.1007\/s00520-010-1073-9","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"3","key":"3080_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11912-013-0312-x","volume":"15","author":"M Trammel","year":"2013","unstructured":"Trammel M, Roederer M, Patel J, McLeod H (2013) Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists? Curr Oncol Rep 15(3):276\u2013285. doi: 10.1007\/s11912-013-0312-x","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"3080_CR18","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.3747\/co.19.1074","volume":"19","author":"N Bouganim","year":"2012","unstructured":"Bouganim N, Dranitsaris G, Hopkins S, Vandermeer L, Godbout L, Dent S, Wheatley-Price P, Milano C, Clemons M (2012) Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting. Curr Oncol(Toronto, Ont) 19(6):e414\u2013e421. doi: 10.3747\/co.19.1074","journal-title":"Curr Oncol(Toronto, Ont)"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3080-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T19:01:54Z","timestamp":1654110114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3080-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]}}}